Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Subacute Oral Toxicity Assesment of Ethanol Extract of Mariposa christia vespertilionis Leaves in Male Sprague Dawley Rats.

Nurul SAS, Hazilawati H, Mohd RS, Mohd FHR, Noordin MM, Norhaizan ME.

Toxicol Res. 2018 Apr;34(2):85-95. doi: 10.5487/TR.2018.34.2.085. Epub 2018 Apr 15.

2.

The Long-Term Outcomes for Patients with Budd-Chiari Syndrome Caused by Behcet's Disease: A Case Series on the Results, from Cirrhosis to Death.

Cansu DU, Temel T, Erturk A, Kasifoglu T, Acu B, Korkmaz C.

Hepat Mon. 2016 Sep 19;16(10):e32457. eCollection 2016 Oct.

3.

Liver cirrhosis in hepatic vena cava syndrome (or membranous obstruction of inferior vena cava).

Shrestha SM.

World J Hepatol. 2015 Apr 28;7(6):874-84. doi: 10.4254/wjh.v7.i6.874. Review.

4.

Budd-Chiari syndrome with multiple large regenerative nodules.

Kim H, Nahm JH, Park YN.

Clin Mol Hepatol. 2015 Mar;21(1):89-94. doi: 10.3350/cmh.2015.21.1.89. No abstract available.

5.

A Rare Presentation of an Entrapment in a Liver Transplant Candidate Depicted by MDCT Angiography.

Kantarci M, Aydin U, Doganay S, Aydinli B, Yuce I, Polat KY.

Eurasian J Med. 2010 Aug;42(2):95-7. doi: 10.5152/eajm.2010.26.

6.

Pathological Diagnosis of Hepatocellular Cellular Adenoma according to the Clinical Context.

Bioulac-Sage P, Sempoux C, Possenti L, Frulio N, Laumonier H, Laurent C, Chiche L, Frédéric Blanc J, Saric J, Trillaud H, Le Bail B, Balabaud C.

Int J Hepatol. 2013;2013:253261. doi: 10.1155/2013/253261. Epub 2013 Apr 18.

7.

Multiple FNH-Like Lesions in a Patient with Chronic Budd-Chiari Syndrome: Gd-EOB-Enhanced MRI and BR1 CEUS Findings.

Newerla C, Schaeffer F, Terracciano L, Hohmann J.

Case Rep Radiol. 2012;2012:685486. doi: 10.1155/2012/685486. Epub 2012 Mar 11.

8.

Hepatocellular carcinoma in Budd-Chiari syndrome: a single center experience with long-term follow-up in South Korea.

Park H, Yoon JY, Park KH, Kim DY, Ahn SH, Han KH, Chon CY, Park JY.

World J Gastroenterol. 2012 Apr 28;18(16):1946-52. doi: 10.3748/wjg.v18.i16.1946.

9.

Rapid development of a hepatocellular carcinoma in isolated thrombosis of hepatic veins (classic Budd-Chiari syndrome): case report and review of literature.

Walldorf J, Tannapfel A, Holzhausen HJ, Wittekind C, Seufferlein T, Settmacher U, Fleig WE, Dollinger MM.

BMJ Case Rep. 2009;2009. pii: bcr07.2009.2057. doi: 10.1136/bcr.07.2009.2057. Epub 2009 Nov 29.

10.

Viral cirrhosis: an overview of haemostatic alterations and clinical consequences.

Ponziani FR, De Stefano V, Gasbarrini A.

Mediterr J Hematol Infect Dis. 2009 Dec 30;1(3):e2009033. doi: 10.4084/MJHID.2009.033.

11.

Liver cirrhosis and hepatocellular carcinoma in hepatic vena cava disease, a liver disease caused by obstruction of inferior vena cava.

Shrestha SM.

Hepatol Int. 2009 Jun;3(2):392-402. doi: 10.1007/s12072-009-9122-5. Epub 2009 Jan 23.

12.

Characteristics of common solid liver lesions and recommendations for diagnostic workup.

Assy N, Nasser G, Djibre A, Beniashvili Z, Elias S, Zidan J.

World J Gastroenterol. 2009 Jul 14;15(26):3217-27. Review.

13.

Budd-Chiari syndrome: etiology, pathogenesis and diagnosis.

Aydinli M, Bayraktar Y.

World J Gastroenterol. 2007 May 21;13(19):2693-6. Review.

14.

Hepatic venous outflow obstruction: three similar syndromes.

Bayraktar UD, Seren S, Bayraktar Y.

World J Gastroenterol. 2007 Apr 7;13(13):1912-27. Review.

15.

Etiology and consequences of thrombosis in abdominal vessels.

Bayraktar Y, Harmanci O.

World J Gastroenterol. 2006 Feb 28;12(8):1165-74. Review.

16.

Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the disease.

Paradis V, Bièche I, Dargère D, Cazals-Hatem D, Laurendeau I, Saada V, Belghiti J, Bezeaud A, Vidaud M, Bedossa P, Valla DC.

Gut. 2005 Dec;54(12):1776-81. Epub 2005 Sep 14.

17.

The utility of TIPS in the management of Budd-Chiari syndrome.

Molmenti EP, Segev DL, Arepally A, Hong J, Thuluvath PJ, Rai R, Klein AS.

Ann Surg. 2005 Jun;241(6):978-81; discussion 982-3.

18.

Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease.

Ward NL, Haninec AL, Van Slyke P, Sled JG, Sturk C, Henkelman RM, Wanless IR, Dumont DJ.

Am J Pathol. 2004 Sep;165(3):889-99.

Supplemental Content

Support Center